Use of a FITLINE to Support Families of Overweight and Obese Children in Pediatric Practices

Lori Pbert1, Susan Druker1, Bruce Barton2

  • 11 Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School , Worcester, MA.

Childhood Obesity (Print)
|January 21, 2016
PubMed

Insights

The FITLINE program effectively reduced children's BMI and improved health behaviors. This pilot study suggests its potential as a pediatric obesity intervention model.

Area of Science:

  • Pediatric obesity intervention
  • Public health nutrition
  • Behavioral health in children

Background:

  • The American Academy of Pediatrics recommends staged approaches for pediatric weight management.
  • This pilot study assessed a pediatric practice-based referral program for overweight/obese children.
  • The program aimed to support parents in improving children's weight-related behaviors and BMI.

Purpose of the Study:

  • To evaluate the preliminary efficacy of the FITLINE telephone counseling program.
  • To determine if the program could help parents guide children in making recommended dietary and activity changes.
  • To assess the program's impact on children's Body Mass Index (BMI) and behaviors.

Main Methods:

  • A nonrandomized intervention study with a contemporaneous control group.
  • Recruited 37 children aged 8-12 with BMI at or above the 85th percentile.
  • Intervention group received nutritionist-guided telephone counseling (FITLINE) for six weeks.
  • Data collected at baseline and 3 months included child BMI and parent-reported behaviors.

Main Results:

  • The FITLINE group showed a mean BMI decrease of -0.49 units, while the control group had a mean increase of 0.35 units.
  • Adjusted analysis revealed a significant BMI reduction in the FITLINE group compared to the control group (mean difference = -0.89).
  • Significant improvements were observed in children's dietary and sedentary behaviors.

Conclusions:

  • The FITLINE program demonstrated short-term effectiveness in reducing pediatric BMI.
  • The program successfully improved children's dietary and sedentary behaviors.
  • Further research via a randomized controlled trial is recommended to validate efficacy and explore its potential as a scalable model.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
335
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
374
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
281
Family Therapy01:30

Family Therapy

Family therapy conceptualizes psychological challenges as arising from dysfunctional interactions within the family unit, rather than as isolated issues within individuals. This approach seeks to address and transform the patterns of communication, roles, and relationships within families to promote healthier dynamics and emotional well-being for all members.
Strategic Family Therapy
Strategic family therapy emphasizes resolving communication barriers and improving problem-solving abilities...
771
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
729